2015, Number 07
<< Back Next >>
Ginecol Obstet Mex 2015; 83 (07)
Rate of human papillomavirus infection in rural areas diagnosed by direct visualization with acetic acid and lugol
Flores-Alatriste JD, Saldívar-Gutiérrez KG, Sarmiento-Ángeles J, Granados-Marín JC, Olaya-Rivera MA, Carlotta S, Flores-Navarro H, Stern-Colin J
Language: Spanish
References: 29
Page: 429-436
PDF size: 435.61 Kb.
ABSTRACT
Background: Infection by HPV is a major global health problem and the
main risk factor for cervical cancer with high morbidity and mortality.
Simple diagnostic methods, such as visual inspection with the naked eye of the cervix with acetic acid application 5% (VAT) or solution of
iodine (tincture of iodine) are simple to detect early lesions, sensitivity
varies from 87 to 99% and specificity varies from 23 to 87%.
Objective: To find the proportion of infection by human papillomavirus
in a population of extreme poverty.
Material and method: Linear, observational and descriptive pilot study
was done in patients of marginalized communities in extreme poverty
in Chiapas (Mexico), from 1 to 30 November 2013. The existence of
acetowhite lesions suggestive of virus was verified human papillomavirus,
and medical history of all patients was formed for the incidence
of risk factors.
Results: 214 women with age limits of 19 and 78 years, median age of
37 years were studied. Of the total, 66 (31%) had acetowhite lesions
consistent with human papillomavirus at the time of the study.
Conclusions: Marginalized populations have a higher risk of infection
with human papillomavirus, consequently high rate of progression to
cervical cancer due to sociodemographic characteristics, risk factors
and lack of resources in health. Diagnostic tests like the simple display
with acetic acid are ideal for people such as this.
REFERENCES
Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papilloma virus and cervical cancer. Lancet 2013;382:889- 99.
Eileen FD, Ina UP. HPV and HPV-associated diseases. Infect Dis Clin N Am 2013;27:765-78
Deodhar KK. Screening for cervical cancer and human papilloma virus: Indian context. Clin Lab Med 2012;32:193-205
Muñoz N, Herrero R. Prevention of cervical cancer in women’s hands: Mexico leads the way. Lancet 2011;378:1829-31.
Weinstein LC, Buchanan EM, Hillson C, Chambers CV. Screening and prevention: cervical cancer. Prim Care 2009;36:559-74.
Denny L. Cervical cancer prevention: new opportunities for primary and secondary prevention in the 21st century. Int J Gynaecol Obstet 2012;119 Suppl 1:S80-4. Epub 2012 Aug 11.
Luciani S, Andrus JK. A Pan American Health Organization strategy for cervical cancer prevention and control in Latin America and the Caribbean. Reprod Health Matters 2008;16:59-66.
Muñoz N, Franco EL, Herrero R, et al. Recommendations for cervical cancer prevention in Latin America and the Caribbean. Vaccine 2008;26 Suppl 11:L96-L107.
Herrero R, Ferreccio C, Salmeron J, et al. New approaches to cervical cancer screening in Latin America and the Caribbean. Vaccine 2008;26 Suppl 11:L49-58.
Spitzer M. Screening and management of women and girls with human papillomavirus infection. Gynecol Oncol 2007;107(2 Suppl 1):S14-8.
Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, et all. Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer 2004;110:907-13.
Sauvaget C, Fayette JM, Muwonge R, Wesley R, Sankaranarayanan R. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecol Obstet 2011;113:14-24. Epub 2011 Jan 22.
Sankaranarayanan R, Nessa A, Esmy PO, Dangou JM.Visual inspection methods for cervical cancer prevention. Best Pract Res Clin Obstet Gynaecol 2012;26:221-32. Epub 2011 Nov 9.
Deodhar K, Sankaranarayanan R, Jayant K, Jeronimo J, Thorat R, et all.
Accuracy of concurrent visual and cytology screening in detecting cervical cancer precursors in rural India. Int J Cancer 2012;131:E954-62. Epub 2012 May 30.
Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, et all.
Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 2005;353:2158-68.
Legood R, Gray AM, Mahé C, Wolstenholme J, et al. Screening for cervical cancer in India: How much will it cost? A trial based analysis of the cost per case detected. Int J Cancer 2005;117:981-7.
Chalkidou K, Marquez P, Dhillon PK, Teerawattananon Y, Anothaisintawee T, et all. Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries. Lancet Oncol. 2014 Mar;15(3):e119-e131.
Kulasingam S, Havrilesky L.Health economics of screening for gynaecological cancers. Best Pract Res Clin Obstet Gynaecol. 2012 Apr;26(2):163-73.
Phongsavan K, Phengsavanh A, Wahlström R, Marions L.Safety, feasibility, and acceptability of visual inspection with acetic acid and immediate treatment with cryotherapy in rural Laos. Int J Gynaecol Obstet. 2011 Sep;114(3):268-72.
Nene BM, Hiremath PS, Kane S, Fayette JM, et all. Effectiveness, safety, and acceptability of cryotherapy by midwives for cervical intraepithelial neoplasia in Maharashtra, India. Int J Gynaecol Obstet. 2008 Dec;103(3):232-6.
Paul P, Winkler JL, Bartolini RM, Penny ME, Huong TT, et all. Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid andcryotherapy: experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam. Oncologist. 2013;18 Suppl:6-12.18-S2-6.
Santesso N, Schünemann H, Blumenthal P, De Vuyst H, Gage J, et all.
World Health Organization Guidelines: Use of cryotherapy for cervical intraepithelial neoplasia. Int J Gynaecol Obstet. 2012 Aug;118(2):97-102.
Pourasad-Shahrak S, Salehi-Pourmehr H, Mostafa- Garebaghi P.
Comparing the results of Pap smear and Direct Visual Inspection (DVI) with 5% acetic acid in cervical cancer screening. Niger Med J. 2015 Jan-Feb; 56(1): 35–38.
Mallah F, Nazari F, Navali N. Comparison of direct visual inspection (DVI) with paps mear in diagnosis of precancer our lesion of cervix. Life Sci J. 2012;9:2556–60.
WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention. WHO Guidelines Approved by the Guidelines Review Committee. Geneva: World Health Organization; 2013.
Full text